Camille E G Glaus
Biographic Data
| ID | 10434435 |
|---|---|
| NAME | Camille E G Glaus |
| GIVEN NAMES | Camille E G |
| FAMILY NAME | Glaus |
| SIGNATURE | GLAUS C E G |
| AFFILIATIONS | University of Zurich |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021
Importance The number of drugs approved through the accelerated approval or conditional marketing authorization pathways has increased with unclear evidence of their therapeutic value. Objectives To assess the therapeutic value of drug indications granted accelerated approval in the US or conditional marketing authorization in the European Union (EU) overall and for cancer indications. Design, Setting, and Participants This cohort study used the …
No prominent works on this page.
Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021
Importance The number of drugs approved through the accelerated approval or conditional marketing authorization pathways has increased with unclear evidence of their therapeutic value. Objectives To assess the therapeutic value of drug indications granted accelerated approval in the US or conditional marketing authorization in the European Union (EU) overall and for cancer indications. Design, Setting, and Participants This cohort study used the …
Agency (philosophy (1 work) · Authorization (1 work) · Bioinformatics (1 work) · Business (1 work) · Cohort (1 work) · Drug (1 work) · European union (1 work) · Family medicine (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work)